http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007135967-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007135967-A |
| titleOfInvention | REGENERATING ANTI-INFLAMMATORY PRODUCT AND METHODS OF TREATMENT USING THIS PRODUCT |
| abstract | 1. A regenerating anti-inflammatory agent, which is an aqueous solution of the active principle - comenic acid and auxiliary substance - sodium bicarbonate, in the following ratio, wt.%:! Comenic acid 1-2, mainly 1 and 2 Sodium bicarbonate 0.55-1.1 Water for injection up to 100! 2. The regenerating anti-inflammatory agent according to claim 1, characterized in that it additionally contains an admixture of comenic acid - benzylcomenic acid - in an amount of not more than 2.5% in terms of comenic acid. ! 3. A method for the treatment of chorioretinal dystrophies of various etiologies, which consists in administering to the patient a regenerating agent according to claims 1 to 2 parabulbar at a dose of 10 to 20 mg (in terms of comenic acid) once a day for 10 days. ! 4. The treatment method according to claim 3, characterized in that the course of treatment is repeated 2-3 times a year. ! 5. The treatment method according to claim 3, characterized in that the patient is administered a regenerating agent in one or both eyes. ! 6. A way to increase the effectiveness of anti-tuberculosis therapy, which consists in the fact that the patient is administered a regenerating agent according to claims 1 to 2 intravenously at a dose of up to 350 mg per day (in terms of comenic acid) for 10 days. ! 7. The treatment method according to claim 6, characterized in that the course of treatment is carried out 1-3 times a year with a break of 3-6 months. |
| priorityDate | 2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.